Mendota Financial Group LLC Invests $36,000 in Everus (NYSE:ECG)

Mendota Financial Group LLC purchased a new stake in Everus (NYSE:ECGFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 553 shares of the company’s stock, valued at approximately $36,000.

Separately, Forza Wealth Management LLC bought a new position in shares of Everus during the fourth quarter worth approximately $336,000.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ECG. Wolfe Research assumed coverage on Everus in a report on Tuesday, December 3rd. They issued a “peer perform” rating for the company. Stifel Nicolaus increased their price objective on shares of Everus from $71.00 to $78.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. DA Davidson started coverage on shares of Everus in a research report on Monday, November 4th. They issued a “neutral” rating and a $55.00 target price for the company. Finally, Oppenheimer increased their price target on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 7th.

Check Out Our Latest Report on Everus

Everus Price Performance

Shares of NYSE:ECG opened at $65.87 on Tuesday. The company has a 50 day moving average of $65.03. Everus has a one year low of $40.05 and a one year high of $73.73. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47.

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Recommended Stories

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.